In this study, we found that UCA1 overexpression promoted cetuximab resistance, both in vitro and in vivo, confirming its role in anticancer drug resistance in CRC, which was consistent with previous similar findings 41. The gene discussed is UCA1; the disease is colorectal carcinoma.